AKTS
Aktis Oncology, Inc.NASDAQStock$28.45-2.70 (-8.67%)Mkt Cap 1.5BP/E —Div Yield —Beta 1.10Vol 494.0KAvg Vol 487.7K
52W$15.19
$31.15
ETFs That Hold AKTS (Aktis Oncology, Inc.)
1M
+44.10%
3M
+77.99%
6M
+31.43%
YTD
+31.43%
1Y
+31.43%
3Y
+852.75%
5Y
+170.09%
ETFs That Hold AKTS
Aktis Oncology, Inc. is held by 23 ETFs. The largest position by market value is in IWM (iShares Russell 2000 ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| IRTR | iShares LifePath Retirement ETF | 0.00% |
Excludes leveraged and inverse ETFs.
PreviousPage 2 of 2
Frequently Asked Questions
How many ETFs hold AKTS?
Aktis Oncology, Inc. (AKTS) is held by 23 ETFs (excluding leveraged and inverse funds). The largest position by market value is in IWM (iShares Russell 2000 ETF).
What is the largest ETF that holds AKTS?
By fund size, IWM (iShares Russell 2000 ETF) with $83.05B in AUM holds 0.02% of its portfolio in AKTS, representing $13.9M in market value.
What percentage of BBC is AKTS?
AKTS makes up 0.87% of BBC (Virtus Biotech Clinical Trials ETF), making it one of the largest positions in that fund.
Is AKTS in the S&P 500?
AKTS is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.